| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methocarbamol | 532-03-6 | sc-211809 sc-211809-CW | 1 g 1 g | $205.00 $390.00 | ||
Methocarbamol exhibits intriguing properties as a central nervous system depressant, characterized by its ability to modulate neurotransmitter release through allosteric interactions. Its unique steric configuration allows for selective binding to specific receptor sites, influencing synaptic transmission dynamics. The compound's hydrophilic nature enhances its solubility, facilitating rapid distribution in biological systems. Additionally, its kinetic profile suggests a complex interplay with metabolic pathways, affecting its overall bioavailability and efficacy. | ||||||
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
Acetazolamide is a widely used carbonic anhydrase I inhibitor. It is primarily studied in the research for glaucoma, as it reduces the production of intraocular fluid, thus lowering the intraocular pressure. | ||||||
Methazolamide | 554-57-4 | sc-235615 | 1 g | $94.00 | 3 | |
Methazolamide is another carbonic anhydrase I inhibitor that works by decreasing the production of aqueous humor, thereby reducing intraocular pressure. | ||||||
Dorzolamide | 120279-96-1 | sc-337687 | 1 g | $960.00 | 2 | |
Dorzolamide is a topical carbonic anhydrase I inhibitor used in the research of glaucoma. It helps reduce intraocular pressure by inhibiting carbonic anhydrase I in the ciliary body. | ||||||
Sulthiame | 61-56-3 | sc-474559 sc-474559A | 25 mg 250 mg | $357.00 $2497.00 | ||
Sultiame is an carbonic anhydrase I inhibitor that is primarily studied in the research for certain types of epilepsy. It is used as an adjunctive therapy to control seizures and has additional mechanisms of action beyond carbonic anhydrase inhibition. | ||||||